Hanjoon Alex Kim's most recent trade in Standard BioTools Inc was a trade of 2,583 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on May 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.09 per share. | 28 May 2025 | 2,583 | 927,703 (1%) | 0% | 1.1 | 2,815 | Common Stock |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.94 per share. | 23 May 2025 | 1,428 | 930,286 (1%) | 0% | 0.9 | 1,344 | Common Stock |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 22 May 2025 | 1,355 | 931,714 (1%) | 0% | 1.0 | 1,358 | Common Stock |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.05 per share. | 20 May 2025 | 6,364 | 934,476 (1%) | 0% | 1.0 | 6,682 | Common Stock |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 20 May 2025 | 1,407 | 933,069 (1%) | 0% | 1.0 | 1,449 | Common Stock |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2025 | 70,183 | 70,183 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2025 | 70,183 | 962,281 (1%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.07 per share. | 04 Apr 2025 | 21,441 | 940,840 (1%) | 0% | 1.1 | 22,942 | Common Stock |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 507,500 | 507,500 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 338,333 | 892,098 (1%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 750,000 | 750,000 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 333,333 | 544,401 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2024 | 70,702 | 211,068 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 70,183 | 140,366 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 70,183 | 140,366 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2023 | 70,183 | 210,549 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2023 | 70,183 | 70,183 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 1,617,775 | 1,617,775 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 280,732 | 280,732 | - | - | Restricted Stock Units |